Target intelligence / Profile preview

Non-ROR1 messenger RNA with partial complementarity to the shROR1 guide strand

Molecular classification
mRNA, Other
01

Overview

Non-ROR1 messenger RNAs with partial complementarity to the shROR1 guide strand refers to a collection of transcripts that are unintentionally silenced by short hairpin RNAs (shRNAs) designed to target the ROR1 (Receptor tyrosine kinase-like orphan receptor 1) gene. This off-target effect is primarily driven by the "seed sequence" of the shRNA, which consists of nucleotides 2 through 7 or 8 of the guide strand. These sequences can bind with partial complementarity to the 3' untranslated regions (UTRs) of various essential genes, leading to their degradation or translational repression (Putzbach et al., 2017, eLife). The broad silencing of these essential survival genes triggers a potent form of cell death known as Death Induced by Survival gene Elimination (DISE) (Gao et al., 2018, Nature Communications). In the context of oncology research, this phenomenon has caused significant confusion, as the cell death observed upon ROR1 knockdown was often mistakenly attributed to the loss of ROR1 itself rather than these off-target effects. This highlights a major challenge in RNA interference (RNAi) therapeutics, where the specificity of the guide strand is paramount to avoiding unintended toxicity. These mRNAs are not therapeutic targets in the traditional sense but are critical factors in understanding the safety profile and mechanism of action of RNAi-based tools and drugs. Consequently, researchers must employ rigorous controls, such as C911 controls or multiple independent sequences, to distinguish between true target-mediated effects and DISE-mediated off-target toxicity.

Other names
DISE-associated mRNAsshRNA off-target transcripts6mer seed toxicity targetsOff-target survival gene mRNAs
02

Mechanism of action

RNA interference-mediated gene silencing via seed-sequence complementarity in the 3' UTR

03

Biological functions

Cell survivalProtein translationOther
04

Disease associations

CancerOther
05

Safety considerations

Off-target toxicityDeath Induced by Survival gene Elimination (DISE)Experimental artifact in target validation
06

Interacting drugs

shROR1 (experimental RNAi agent)

1 more in the full profile.

07

Biomarkers

3' UTR seed match enrichmentSeed sequence toxicity profile

Beyond the preview

Go deeper on Non-ROR1 messenger RNA with partial complementarity to the shROR1 guide strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-ROR1 messenger RNA with partial complementarity to the shROR1 guide strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call